Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 3Squamous Cell Carcinoma of Head and Neck 2Neoplasms 2Colorectal Neoplasms 2Colonic Neoplasms 2Adenomatous Polyposis Coli 2Pathologic Complete Response 1Pancreatic Intraductal Neoplasms 1Pain 1Leukoplakia, Oral 1Leukemia, Myeloid, Acute 1Inflammation 1Hypertension 1Coproporphyria 1Aberrant Crypt Foci 1

Interventions

Exercise 5Vitamin D 3Resistance Training 3Ascorbic Acid 3salicylsalicylic acid 2palbociclib 2epigallocatechin gallate 2Tea 2Tablets 2Surgical Procedures, Operative 2Sufentanil 2Spironolactone 2Oxycodone 2Omeprazole 2Nutrition Assessment 2Morphine 2Metformin 2Ketorolac 2Infliximab 2Ibuprofen 2Fish Oils 2Endurance Training 2Dexmedetomidine 2Blood Specimen Collection 2Aspirin 2ziprasidone 1soybean oil, phospholipid emulsion 1semaglutide 1montelukast 1microcrystalline cellulose 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Inflammation × Sulindac × Clear all
NCT01761877 2023-02-10

NSAID Effects on Clinical and Imaging Breast Biomarkers

Stony Brook University

Phase 2 Completed
114 enrolled 11 charts
Breast

Breast Neoplasms, Hypertension, Inflammation, Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡